神经脂质地图:神经退行性疾病的脂质学资源
Femke M Feringa1, Sascha J Koppes-den Hertog1,2, Lian Y Wang3
1Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Nature metabolism
|September 22, 2025
概括
神经脂质图谱 (Neurolipid Atlas) 是一个新的大脑脂质组学数据库,它揭示了不同的细胞脂质概况,并将星球细胞中的胆固醇积与阿尔茨海默病风险联系起来.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 生物化学 生物化学
背景情况:
- 脂质变化与神经退行性疾病有关.
- 对比性脂质组学研究对于理解这些疾病至关重要.
研究的目的:
- 建立神经脂质地图,这是大脑脂质组学中常见的数据.
- 促进对神经退行性疾病进行比较性脂质组学研究.
主要方法:
- 预先填充了与异位诱导多能干细胞 (iPS细胞) 衍生的脂管组学数据共同的数据.
- 包括人类和小鼠大脑组织的脂管学数据.
- 利用多个数据集来分析脂质资料.
主要成果:
- 在iPS细胞衍生的神经元,微质细胞和星体细胞中显示出明显的脂质特征,这些神经元和星体细胞反映了体内数据.
- 表明阿尔茨海默氏病 (AD) 风险基因ApoE4导致胆固醇在人类星球细胞中积累.
- 从AD患者的全脑脂质组中观察到胆固醇积.
结论:
- 改变胆固醇代谢显著影响天体细胞免疫路径,包括免疫蛋白酶和MHC I类抗原呈现.
- 神经脂质地图表作为一个有价值的资源,用于数据沉积和知识的发现在神经退行性脂质dyshomeostasis.
相关概念视频
Nervous Tissue: Myelin
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...


